Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Aerpio Pharmaceuticals Inc.
ARPO
$
1.25
-3.8%
Tue September 1st, 2020
20:30
Press Releases
Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients
PR Newswire
Wed August 12th, 2020
17:03
Earnings
Analysis
Aerpio Pharmaceuticals' (ARPO) Management on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Wed August 5th, 2020
13:38
Press Releases
Analysis
Thinking about buying stock in Sorrento Therapeutics, Aerpio Pharmaceuticals, Horizon Therapeutics, Riot Blockchain, or Royal Caribbean Cruises?
PR Newswire
Mon June 29th, 2020
21:50
Analysis
Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should Know
Zacks
Mon June 22nd, 2020
11:24
Analysis
Aerpio Pharmaceuticals' Shares March Higher, Can It Continue?
Zacks
Fri June 19th, 2020
21:45
Analysis
Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know
Zacks
Fri June 12th, 2020
15:30
Analysis
Is Aerpio Pharmaceuticals (ARPO) Stock Outpacing Its Medical Peers This Year?
Zacks
+ 1 more
Thu May 28th, 2020
13:31
Press Releases
Analysis
Thinking about buying stock in Aerpio Pharmaceuticals, Axcella Health, General Electric, Zomedica Pharmaceuticals, or Avis Budget Group?
PR Newswire
Wed May 27th, 2020
20:30
Press Releases
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients
PR Newswire
15:30
Analysis
Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?
Zacks
Thu May 21st, 2020
16:00
Rating
Analysis
Aerpio Pharmaceuticals, Inc. (ARPO) Upgraded to Strong Buy: Here's Why
Zacks
